Literature DB >> 8390282

Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.

J K Cowell1, N Groves, P Baird.   

Abstract

Loss of heterozygosity (LOH) in tumour cells is generally accepted as 'exposing' recessive cancer genes. The short arm of chromosome 11 shows consistent LOH in Wilms' tumours along its entire length. Occasionally, however, only the 11p13 and/or the 11p15 regions are involved. Deletions of the 11p13 region consistently predisposes to Wilms' tumorigenesis. We have analysed the recently cloned WT1 gene from the 11p13 region exon-by-exon in five tumours previously shown to have undergone LOH for the 11p13 region, using single strand conformation polymorphism analysis (SSCP) and PCR sequencing. Our analysis using SSCP failed to identify any band shifts in the WT1 gene from these tumours. In addition we also sequenced the zinc finger region of WT1, which is the part of the gene most frequently showing mutations. Only the normal sequence was found in all of these tumours. These results demonstrate that LOH in Wilms' tumours is not always related to mutations in the WT1 genes and argues strongly that another gene, probably in the 11p15 region, may be more important in Wilms' tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390282      PMCID: PMC1968481          DOI: 10.1038/bjc.1993.235

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.

Authors:  K Tadokoro; H Fujii; A Ohshima; Y Kakizawa; K Shimizu; A Sakai; K Sumiyoshi; T Inoue; Y Hayashi; M Yamada
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

2.  Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype.

Authors:  Z Onadim; A Hogg; P N Baird; J K Cowell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.

Authors:  K Pritchard-Jones; S Fleming
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

4.  Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing.

Authors:  A Hogg; Z Onadim; P N Baird; J K Cowell
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

5.  Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.

Authors:  P N Baird; A Santos; N Groves; L Jadresic; J K Cowell
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

6.  Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.

Authors:  P N Baird; N Groves; D A Haber; D E Housman; J K Cowell
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

7.  Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome.

Authors:  M Waziri; S R Patil; J W Hanson; J A Bartley
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

8.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.

Authors:  J Pelletier; W Bruening; C E Kashtan; S M Mauer; J C Manivel; J E Striegel; D C Houghton; C Junien; R Habib; L Fouser
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

9.  A general theory of carcinogenesis.

Authors:  D E Comings
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

10.  Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.

Authors:  K W Brown; J E Watson; V Poirier; M G Mott; P J Berry; N J Maitland
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

View more
  1 in total

1.  Molecular genetic analysis of chromosome 11p in familial Wilms tumour.

Authors:  P N Baird; J Pritchard; J K Cowell
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.